Education
- Doctor of Philosophy, Tufts University, USA, 2001
- Bachelor of Science, Univ Of Massachusetts, USA, 1993
Biography
Experienced drug discovery Project Team Leader and mechanistic enzymologist
Venture-oriented career path: launch roles in 3 startups and 1 multinational pharma site build
Co-discovered first gain-of-function mutations in cancer metabolism (IDH1 and IDH2), and first oncometabolite (2-hydroxyglutaric acid, 2HG). Lead biochemist on IDH program; IDHIFA(Enasidenib) FDA approved Aug17, TIBSOVO(Ivosidenib) approved July18